| Bioactivity | PPACK II diTFA is an irreversible and specific glandular and plasma kallikreins inhibitor[1]. | ||||||
| Invitro | PPACK II (0.62-50 μg/mL) diTFA 显着抑制 B 型钠尿肽 (BNP) 蛋白水解[2]。 | ||||||
| Name | PPACK II diTFA | ||||||
| CAS | 649748-23-2 | ||||||
| Formula | C29H35ClF6N6O7 | ||||||
| Molar Mass | 729.07 | ||||||
| Appearance | Solid | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Kentaro Takayama, et al. Identification of a degrading enzyme in human serum that hydrolyzes a C-terminal core sequence of neuromedin U. Biopolymers. 2016 Nov 4;106(4):440-5. [2]. Alexander Belenky, et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin Chim Acta. 2004 Feb;340(1-2):163-72. |